- Biocair’s new membership with BioNJ is set to enhance its support and services for New Jersey’s life sciences sector.
- BioNJ facilitates collaboration among industry leaders, academia, and investors to drive medical innovation and economic growth.

Biocair has joined BioNJ, the life sciences industry association in New Jersey, to enhance its logistics support within the state’s biopharmaceutical sector. The partnership was announced on July 30, 2024.
BioNJ plays a crucial role in supporting New Jersey’s biopharmaceutical industry by fostering partnerships that drive innovation and growth. The association connects various stakeholders to support advancements in the sector.
Jeff Stone, US General Manager at Biocair, commented, “Joining BioNJ represents a significant milestone for Biocair as we continue to expand our footprint in key life science hubs across the US. We are excited to collaborate with BioNJ and its esteemed members to contribute to the advancement of life sciences and ensure the highest standards of logistics support.”
Debbie Hart, President and CEO of BioNJ, expressed enthusiasm about the new partnership: “We are thrilled to welcome Biocair to BioNJ. Their expertise in global logistics and commitment to excellence will undoubtedly enrich our membership community and contribute to our collective efforts to propel the life sciences industry forward.”